SNY | SanofiNASDAQADR golden cross and death cross projections, cross tests and history

$45.33
-$0.22 (-0.48%)

Sanofi (SNY) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since May 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $45.33 vs 50 $42.19 / 200 $44.31
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 May 2025 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $44.34 vs 50 $45.16 / 200 $49.41
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 16 Feb 2026 ยท projected 18 bars out ยท tested 1 bar

Cross history

41
crosses on record since 2017
19 golden22 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Sep 2026Death4-hour25 bars outNot tested
31 Aug 2026Golden4-hour30 bars out4 bar cross test
5 May 2026Death4-hour10 bars outNot tested
29 Apr 2026Golden4-hour22 bars out1 bar cross test
week of 16 Feb 2026Death flatweekly18 bars out1 bar cross test

About SNY

ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$117M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.